ACCESS Newswire
Jaguar Health Secures an Additional $3 Million Payment from Future Pak for Mytesi and Canalevia-CA1
📈
AI Sentiment
Highly Positive
8/10
- Home
- JAGX
JAGX
Jaguar Health Inc.
as of 03-09-2026 3:41pm EST
$0.49
$0.11
-17.89%
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | SAN FRANCISCO |
| Market Cap: | 2.6M | IPO Year: | 2014 |
| Target Price: | $60.00 | AVG Volume (30 days): | 400.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -22.61 | EPS Growth: | -7201.12 |
| 52 Week Low/High: | $0.20 - $15.48 | Next Earning Date: | N/A |
| Revenue: | $11,689,000 | Revenue Growth: | 19.75% |
| Revenue Growth (this year): | 22.41% | Revenue Growth (next year): | 30.00% |
| P/E Ratio: | -0.03 | Index: | N/A |
| Free Cash Flow: | -29400000.0 | FCF Growth: | N/A |
Latest Jaguar Health Inc. News
JAGX Breaking Stock News: Dive into JAGX Ticker-Specific Updates for Smart Investing
Compare JAGX vs Leading Stocks
See how JAGX stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "JAGX Jaguar Health Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.